- Home
- ARTW vs EVAX Comparison
ARTW vs EVAX Comparison
Compare ARTW & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- EVAX
- Stock Information
- Founded
- ARTW 1956
- EVAX 2008
- Country
- ARTW United States
- EVAX Denmark
- Employees
- ARTW N/A
- EVAX N/A
- Industry
- ARTW Industrial Machinery/Components
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARTW Industrials
- EVAX Health Care
- Exchange
- ARTW Nasdaq
- EVAX Nasdaq
- Market Cap
- ARTW 23.5M
- EVAX 17.8M
- IPO Year
- ARTW N/A
- EVAX 2021
- Fundamental
- Price
- ARTW $3.04
- EVAX $2.86
- Analyst Decision
- ARTW
- EVAX Strong Buy
- Analyst Count
- ARTW 0
- EVAX 2
- Target Price
- ARTW N/A
- EVAX $10.00
- AVG Volume (30 Days)
- ARTW 57.1K
- EVAX 89.0K
- Earning Date
- ARTW 10-03-2025
- EVAX 10-30-2025
- Dividend Yield
- ARTW N/A
- EVAX N/A
- EPS Growth
- ARTW N/A
- EVAX N/A
- EPS
- ARTW 0.44
- EVAX N/A
- Revenue
- ARTW $23,523,353.00
- EVAX $3,176,000.00
- Revenue This Year
- ARTW N/A
- EVAX N/A
- Revenue Next Year
- ARTW N/A
- EVAX N/A
- P/E Ratio
- ARTW $8.40
- EVAX N/A
- Revenue Growth
- ARTW N/A
- EVAX 1042.45
- 52 Week Low
- ARTW $1.43
- EVAX $1.20
- 52 Week High
- ARTW $4.71
- EVAX $17.20
- Technical
- Relative Strength Index (RSI)
- ARTW 46.05
- EVAX 51.80
- Support Level
- ARTW $2.89
- EVAX $2.71
- Resistance Level
- ARTW $3.27
- EVAX $3.04
- Average True Range (ATR)
- ARTW 0.26
- EVAX 0.20
- MACD
- ARTW -0.05
- EVAX -0.01
- Stochastic Oscillator
- ARTW 18.07
- EVAX 59.70
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.